by Sue Robbins | Nov 10, 2014 | Headache Drugs
Researchers developing a novel nasal spray presented their work at the 2014 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in San Diego, Nov. 2-6. Venkata Yellepeddi, Ph.D., along with his colleagues from Roseman University of...
by Sue Robbins | Nov 7, 2014 | Headache Drugs
Digital writer, Anna Altman of The New York Times recently wrote an article bringing attention to the “confounding condition.” Here is her article…. When Susanna Styron’s daughter, Emma, was 14, she began to have migraines. Emma would retreat...
by Sue Robbins | Nov 6, 2014 | Headache Drugs
“Before the headache: Infant colic as an early life expression of migraine” published in the journal Neurology was a cross-sectional study performed in general pediatric clinics. Childhood periodic syndromes are thought to be early-life expressions of the...
by Sue Robbins | Nov 4, 2014 | Headache Drugs
To evaluate the association between migraine and cognitive decline among women, a total of 6,349 women aged 65 or older enrolled in the Women’s Health Study. The women provided information about migraine status at baseline and participated in cognitive testing...
by Sue Robbins | Nov 3, 2014 | Headache Drugs
Electricity has been used for headache since Roman times. In the first century AD, the black torpedo fish (electric ray) was (apparently successfully) applied to the pain. The 2 devices to recently come to the market in the US are the Cefaly (TENS) unit, and the...
by Sue Robbins | Oct 31, 2014 | Headache Drugs
Sumatriptan delivered in an electric patch form applied to the skin was approved by the Federal Drug Administration (FDA) IN 2013 for the acute treatment of migraine. The iontophoretic sumatriptan patch is anticipated to become available in the U.S. in early or...
